LENZ Therapeutics LENZ
NASDAQ LENZ
$4.68 +0.02 (+0.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

LENZ Therapeutics (LENZ) Gains from Investment Securities (2023 - 2024)

LENZ Therapeutics (LENZ) posted quarterly Gains from Investment Securities of $1.0 million for Q1 2024, up 6443.75% year-over-year from $16000.0 in Q2 2023, and up 489.22% quarter-over-quarter from -$269000.0 in Q4 2023.

LENZ Therapeutics (LENZ) Gains from Investment Securities (2023 - 2024) Analysis & Trends

LENZ Therapeutics (LENZ) has reported Gains from Investment Securities for 2 consecutive years, with $1.0 million the latest figure, recorded in Q1 2024.

  • In Q1 2024, Gains from Investment Securities rose 6443.75% year-over-year to $1.0 million; the TTM figure through Dec 2024 stood at $1.0 million (up 951.22% YoY), while the FY2024 annual figure was $1.0 million, up 951.22% from the prior year.
  • Gains from Investment Securities improved to $1.0 million in Q1 2024 per LENZ's latest filing, from -$269000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.0 million in Q1 2024 and bottomed at -$269000.0 in Q4 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 LENZ Therapeutics 147.30 Mn 147.30 Mn 5.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 1.05 Mn
Mar 31, 2024 1.05 Mn
Dec 31, 2023 -269,000.00
Dec 31, 2023 -269,000.00
Sep 30, 2023 106,000.00
Sep 30, 2023 106,000.00
Jun 30, 2023 24,000.00
Jun 30, 2023 24,000.00
Mar 31, 2023 16,000.00
Mar 31, 2023 16,000.00